Search results
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Digital Journal· 6 hours ago(NASDAQ:MRNA) today announced that the Company will present data from its respiratory portfolio, including vaccines and vaccine candidates against COVID-19 (mRNA& ...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 2 days agoResearchers also detected a statistical signal for seizures after vaccination with the BNT162b2...
mRNA Therapeutics Market is Estimated to be USD 45.85 billion by 2031; Driven by Innovative...
Digital Journal· 6 days agoAccording to SNS Insider, the mRNA Therapeutics market will be reaching USD 45.85 billion by 2031 and will be growing at a CAGR of 1.7% over the forecast period of 2024-2031 ...
Only One Harm From mRNA COVID Vaccines, Report Determines
MedPage Today· 1 week ago...time, the National Academies of Sciences, Engineering, and Medicine (NASEM) committee rejected a...
COVID Shot Boosts Mucosal Immunity in Previously Infected People
MedPage Today· 3 days agoOnly 'traces' of spike-specific salivary antibodies found in vaccinated SARS-CoV-2-naive people
Building a Scientific Narrative
The Scientist· 2 weeks agoWhat Is a Scientific Narrative? The narrative in a scientific story aims to contextualize generated data2 in a way that answers the following questions....
Vaccine Safety and DMT for Highly Active MS: New Data
Medscape· 2 days agoMany clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.